Bolivia vs Madagascar: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Bolivia
59.0%
in 2025
Madagascar
56.0%
in 2025
Bolivia rank
148th
Madagascar rank
151st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Bolivia
- Madagascar
How they compare
Bolivia currently reports 59.0% against 56.0% in Madagascar, a difference of 3.0%.
That makes Bolivia's figure about 1.1 times Madagascar's.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Madagascar ahead.
Bolivia ranks 148th and Madagascar ranks 151st of 194 countries.
Across the 3 decades both report, Bolivia averaged higher in 1 and Madagascar in 1.
Head to head by decade
| Decade | Bolivia | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 47.0% | 47.6% | 0.6% | Madagascar |
| 2020s | 65.5% | 60.7% | 4.8% | Bolivia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Bolivia or Madagascar?
- Bolivia, at 59.0% against 56.0% in Madagascar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Bolivia and Madagascar?
- 3.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Madagascar?
- 18 years are reported by both, from 2008 to 2025.
- How do Bolivia and Madagascar rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Bolivia ranks 148th and Madagascar ranks 151st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.